A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

NCT00142350 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

690

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: continuous infusion of 5-fluorouracil
DRUG: combination of irinotecan and cisplatin
DRUG: oral administration of S-1

Sponsor

Japan Clinical Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]